Tommy Lan
Papers
1
Total Citations
2
H-Index
1
About
Tommy Lan is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for liver cancer treatment, particularly robotic hepatectomy for hepatocellular carcinoma (HCC). His major contribution lies in rigorously comparing robotic versus open surgery for large liver tumors, a critical area where evidence has been scarce. In a landmark, large-volume center study with propensity score matching, Lan demonstrated that robotic hepatectomy for HCC tumors ≥5 cm achieves comparable long-term oncologic outcomes to open surgery, while offering superior perioperative benefits—including reduced blood loss, shorter hospital stays, and lower complication rates. This work, already cited twice since its 2025 publication, provides compelling evidence to expand the role of robotic approaches in complex liver resections. Lan’s research directly addresses a key clinical dilemma, helping surgeons and patients make informed decisions about surgical options. His findings are poised to influence practice guidelines and inspire further prospective trials, solidifying his reputation as a pioneer in robotic hepatobiliary surgery and a driving force in the shift toward less invasive, yet equally effective, cancer care.
Research Focus
Key Achievements
Top Papers
- 1